Clinical Trials Directory

Trials / Conditions / Metastatic Biliary Tract Cancer

Metastatic Biliary Tract Cancer

8 registered clinical trials studyying Metastatic Biliary Tract Cancer — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingEmavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Ad
NCT07107750
Washington University School of MedicinePhase 1
Not Yet RecruitingInetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer
NCT06818773
Eastern Hepatobiliary Surgery HospitalPhase 4
RecruitingCTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Met
NCT06548412
M.D. Anderson Cancer CenterPhase 1 / Phase 2
UnknownEfficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsit
NCT06282120
Tianjin Medical University Cancer Institute and Hospital—
UnknownA Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract C
NCT05742750
Sun Yat-sen UniversityPhase 1 / Phase 2
CompletedNal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer
NCT03524508
Changhoon YooPhase 2
CompletedImmune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cance
NCT02866383
Herlev HospitalPhase 2
TerminatedRandomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
NCT01096745
Gyeongsang National University HospitalPhase 2